Download Citation
Article Source:
NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma
Galipeau PC,
Li X,
Blount PL,
Maley CC,
Sanchez CA,
et al.
(2007)
NSAIDs Modulate CDKN2A, TP53, and DNA Content Risk for Progression to Esophageal Adenocarcinoma.
PLOS Medicine 4(2): e67.
https://doi.org/10.1371/journal.pmed.0040067